Provided by Tiger Fintech (Singapore) Pte. Ltd.

Madrigal Pharmaceuticals

282.72
+3.121.12%
Post-market: 282.720.00000.00%19:26 EDT
Volume:303.69K
Turnover:85.97M
Market Cap:6.28B
PE:-15.74
High:287.27
Open:281.03
Low:275.00
Close:279.60
Loading ...
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 17, 2024

Correspondence

Form CORRESP - Correspondence
Jan 09, 2024

Major Issues Report

Form 8-K - Current report
Dec 14, 2023

Correspondence

Form CORRESP - Correspondence
Dec 14, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Dec 08, 2023

Correspondence

Form CORRESP - Correspondence
Nov 22, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Nov 13, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 06, 2023

Major Issues Report

Form 8-K - Current report
Nov 06, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 06, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Oct 02, 2023

Major Issues Report

Form 8-K - Current report
Sep 25, 2023

Major Issues Report

Form 8-K - Current report
Sep 14, 2023

Major Issues Report

Form 8-K - Current report
Sep 14, 2023

Major Issues Report

Form 8-K - Current report
Sep 13, 2023

Major Issues Report

Form 8-K - Current report
Sep 11, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 09, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Aug 08, 2023

Major Issues Report

Form 8-K - Current report